Organigram Global (NASDAQ:OGI) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Organigram Global (NASDAQ:OGI) from a sell rating to a hold rating in a report released on Saturday.

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Organigram Global in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

Organigram Global Stock Down 6.2%

Shares of OGI stock opened at $1.80 on Friday. Organigram Global has a 12 month low of $0.85 and a 12 month high of $2.08. The company has a market cap of $243.01 million, a PE ratio of 36.01 and a beta of 1.50. The business’s 50 day moving average is $1.67 and its two-hundred day moving average is $1.58.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Tidal Investments LLC increased its stake in Organigram Global by 4.9% during the second quarter. Tidal Investments LLC now owns 2,646,879 shares of the company’s stock valued at $3,573,000 after acquiring an additional 124,356 shares during the period. AdvisorShares Investments LLC grew its holdings in shares of Organigram Global by 31.2% during the 3rd quarter. AdvisorShares Investments LLC now owns 1,052,394 shares of the company’s stock worth $2,136,000 after purchasing an additional 250,000 shares in the last quarter. Two Sigma Investments LP acquired a new stake in shares of Organigram Global during the 3rd quarter worth approximately $907,000. Baader Bank Aktiengesellschaft increased its position in shares of Organigram Global by 5.3% during the third quarter. Baader Bank Aktiengesellschaft now owns 263,915 shares of the company’s stock valued at $519,000 after purchasing an additional 13,271 shares during the period. Finally, Vontobel Holding Ltd. raised its stake in shares of Organigram Global by 140.5% in the second quarter. Vontobel Holding Ltd. now owns 69,753 shares of the company’s stock valued at $94,000 after purchasing an additional 40,753 shares in the last quarter. Institutional investors and hedge funds own 34.63% of the company’s stock.

Organigram Global Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.